Efficacy and Safety of Evocalcet Evaluated by Dialysate Calcium Concentration in Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis

PURPOSE: Evocalcet is a novel oral calcimimetic drug that has demonstrated similar efficacy to cinacalcet in regulating serum parathyroid hormone (PTH), calcium, and phosphate levels, with fewer upper gastrointestinal tract-related adverse drug reactions (ADRs) in patients with secondary hyperparath...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Nephrol Renovasc Dis
Hlavní autoři: Shigematsu, Takashi, Asada, Shinji, Endo, Yuichi, Kawata, Takehisa, Fukagawa, Masafumi, Akizawa, Tadao
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7229806/
https://ncbi.nlm.nih.gov/pubmed/32494184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S243210
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky